Arcturus Therapeutics Holdings Inc. (ARCT)

ARCT Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	641	843	449	976	1,063	164
Market Cap Growth	42.79%	87.53%	-53.94%	-8.18%	546.25%	239.22%
Enterprise Value	325	521	148	673	619	113
PE Ratio	-	-28.35	48.06	-4.79	-14.73	-6.33
PS Ratio	5.15	5.05	2.18	78.94	111.39	7.91
PB Ratio	2.43	3.03	1.66	4.28	2.68	6.38
P/FCF Ratio	65.61	-40.12	18.52	-7.05	-23.82	-22.64
P/OCF Ratio	52.45	-46.55	14.04	-7.22	-24.79	-25.51
EV/Sales Ratio	2.61	3.13	0.72	54.43	64.86	5.43
EV/EBITDA Ratio	-5.11	-12.56	11.78	-3.35	-8.73	-4.54
EV/EBIT Ratio	-4.97	-11.72	13.40	-3.33	-8.62	-4.42
EV/FCF Ratio	33.28	-24.83	6.11	-4.86	-13.87	-15.55
Debt / Equity Ratio	0.10	0.09	0.34	0.30	0.05	0.77
Debt / EBITDA Ratio	-0.24	-0.62	7.22	-0.34	-0.27	-0.80
Debt / FCF Ratio	2.83	-1.23	3.74	-0.49	-0.43	-2.73
Quick Ratio	3.21	4.62	3.11	3.76	9.39	3.45
Current Ratio	3.26	4.72	3.18	3.81	9.45	3.48
Asset Turnover	0.29	0.37	0.58	0.03	0.04	0.29
Interest Coverage	-	-	26.34	-105.02	-198.86	-57.28
Return on Equity (ROE)	-38.70%	-10.10%	4.80%	-71.10%	-37.50%	-116.00%
Return on Assets (ROA)	-24.70%	-6.60%	2.60%	-46.40%	-28.30%	-36.50%
Return on Capital (ROIC)	-42.31%	-25.69%	2.96%	-68.57%	-17.21%	-55.90%
Earnings Yield	-16.75%	-3.53%	2.08%	-20.88%	-6.79%	-15.81%
FCF Yield	1.52%	-2.49%	5.40%	-14.19%	-4.20%	-4.42%
Buyback Yield / Dilution	0.99%	1.72%	-2.95%	-29.61%	-68.24%	-19.86%
Total Shareholder Return	0.99%	1.72%	-2.95%	-29.61%	-68.24%	-19.86%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).